Baltimore, MD and Oslo, Norway - A new classification for measuring bleeding in clinical trials of antithrombotic agents has been proposed that takes into account minor bleeding more than current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback